These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10608352

  • 21. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K, Abei M, Ugai H, Kawashima R, Seo E, Wakayama M, Murata T, Endo S, Hamada H, Hyodo I, Yokoyama KK.
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [Abstract] [Full Text] [Related]

  • 22. An early function of the adenoviral E1B 55 kDa protein is required for the nuclear relocalization of the cellular p53 protein in adenovirus-infected normal human cells.
    Cardoso FM, Kato SE, Huang W, Flint SJ, Gonzalez RA.
    Virology; 2008 Sep 01; 378(2):339-46. PubMed ID: 18632130
    [Abstract] [Full Text] [Related]

  • 23. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.
    Harada N, Maniwa Y, Yoshimura M, Nagata M, Hamada H, Yokono K, Okita Y.
    Oncol Rep; 2005 Nov 01; 14(5):1155-63. PubMed ID: 16211279
    [Abstract] [Full Text] [Related]

  • 24. Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter.
    Sagawa T, Takahashi M, Sato T, Sato Y, Lu Y, Sumiyoshi T, Yamada Y, Iyama S, Fukaura J, Sasaki K, Hamada H, Miyanishi K, Takayama T, Kato J, Niitsu Y.
    Mol Ther; 2004 Dec 01; 10(6):1043-50. PubMed ID: 15564136
    [Abstract] [Full Text] [Related]

  • 25. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Zhang Z, Zou W, Wang J, Gu J, Dang Y, Li B, Zhao L, Qian C, Qian Q, Liu X.
    Mol Ther; 2005 Apr 01; 11(4):553-62. PubMed ID: 15771958
    [Abstract] [Full Text] [Related]

  • 26. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells.
    Steegenga WT, Riteco N, Bos JL.
    Oncogene; 1999 Sep 09; 18(36):5032-43. PubMed ID: 10490840
    [Abstract] [Full Text] [Related]

  • 27. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
    Shinoura N, Yoshida Y, Tsunoda R, Ohashi M, Zhang W, Asai A, Kirino T, Hamada H.
    Cancer Res; 1999 Jul 15; 59(14):3411-6. PubMed ID: 10416603
    [Abstract] [Full Text] [Related]

  • 28. E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.
    Kim J, Kim JH, Choi KJ, Kim PH, Yun CO.
    Hum Gene Ther; 2007 Sep 15; 18(9):773-86. PubMed ID: 17725410
    [Abstract] [Full Text] [Related]

  • 29. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
    Hobom U, Dobbelstein M.
    J Virol; 2004 Jul 15; 78(14):7685-97. PubMed ID: 15220443
    [Abstract] [Full Text] [Related]

  • 30. Analysis of early region 1 of porcine adenovirus type 3.
    Zhou Y, Tikoo SK.
    Virology; 2001 Dec 05; 291(1):68-76. PubMed ID: 11878877
    [Abstract] [Full Text] [Related]

  • 31. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.
    Cancer Res; 2006 Apr 15; 66(8):4291-8. PubMed ID: 16618754
    [Abstract] [Full Text] [Related]

  • 32. In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene.
    Sánchez-Prieto R, Quintanilla M, Martín P, Lleonart M, Cano A, Dotto GP, Ramón y Cajal S.
    Cancer Gene Ther; 1998 Apr 15; 5(4):215-24. PubMed ID: 9694073
    [Abstract] [Full Text] [Related]

  • 33. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
    Tang YX, Chen Y, Gu JF, Qi R, Zou WG, Jiang LL, Liu XY.
    Ai Zheng; 2005 May 15; 24(5):536-42. PubMed ID: 15890093
    [Abstract] [Full Text] [Related]

  • 34. Coexpression of the adenovirus 12 E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus.
    Liao D, Yu A, Weiner AM.
    Virology; 1999 Feb 01; 254(1):11-23. PubMed ID: 9927570
    [Abstract] [Full Text] [Related]

  • 35. [Security of dual cancer-specific targeting vector and its cytotoxic effect when harbored].
    Wang J, Gu JF, Yang SY, Xiao T, Qi R, Sun LY, Liu XY.
    Ai Zheng; 2006 Apr 01; 25(4):385-92. PubMed ID: 16613667
    [Abstract] [Full Text] [Related]

  • 36. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 01; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 37. Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy.
    Hsu KF, Wu CL, Huang SC, Hsieh JL, Huang YS, Chen YF, Shen MR, Chung WJ, Chou CY, Shiau AL.
    Cancer Gene Ther; 2008 Aug 01; 15(8):526-34. PubMed ID: 18497852
    [Abstract] [Full Text] [Related]

  • 38. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO, Gómez-Navarro J, Xiang J, Barnes MN, Mahasreshti P, Alvarez RD, Siegal GP, Badib AO, Buchsbaum D, Curiel DT, Stackhouse MA.
    Mol Ther; 2000 Jun 01; 1(6):545-54. PubMed ID: 10933979
    [Abstract] [Full Text] [Related]

  • 39. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T.
    Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096
    [Abstract] [Full Text] [Related]

  • 40. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5.
    Liu XY, Qiu SB, Zou WG, Pei ZF, Gu JF, Luo CX, Ruan HM, Chen Y, Qi YP, Qian C.
    Mol Ther; 2005 Apr 01; 11(4):531-41. PubMed ID: 15771956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.